Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing Skin Rejuvenation Through Ultrasound-Enhanced Non-Invasive Delivery of Hyaluronic Acid Nanoparticles.

Nanomaterials (Basel, Switzerland)·2025
Same author

Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross-Species Multi-Cohort Bioinformatic Study.

Head & neck·2025
Same author

Pharmacological activation of SIRT6 suppresses progression of head and neck and esophageal squamous cell carcinoma by modulation of cellular metabolism and protein translation.

Cell death & disease·2025
Same author

HLA-E[pHLA-G] complex-specific monoclonal antibody enhancing NK activity in multiple myeloma.

Blood advances·2025
Same author

Targeted siRNA Delivery Using Cetuximab-Conjugated Starch for Epidermal Growth Factor Receptor-Driven Head and Neck Squamous Cell Carcinoma.

Small science·2025
Same author

Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas.

British journal of cancer·2024

Related Experiment Video

Updated: May 12, 2026

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

6.6K

Unravelling the Complexity of HNSCC Using Single-Cell Transcriptomics.

Cristina Conde-Lopez1, Divyasree Marripati2,3, Moshe Elkabets2,3

  • 1Division Radiooncology/Radiobiology, German Cancer Research Center (DKFZ) Heidelberg, 69120 Heidelberg, Germany.

Cancers
|October 16, 2024
PubMed
Summary

Single-cell RNA sequencing (scRNAseq) offers detailed insights into head and neck squamous cell carcinoma (HNSCC) and its tumor microenvironment. This technology aids in understanding HNSCC progression, diagnosis, and treatment responses.

Keywords:
HNSCCsingle-cell RNA sequencingtumor microenvironment

More Related Videos

Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq
06:24

Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq

Published on: March 12, 2021

3.5K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.7K

Related Experiment Videos

Last Updated: May 12, 2026

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

6.6K
Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq
06:24

Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq

Published on: March 12, 2021

3.5K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.7K

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is a complex and common cancer type.
  • Significant challenges exist in managing HNSCC due to its heterogeneity.
  • The tumor microenvironment (TME) plays a critical role in HNSCC progression.

Purpose of the Study:

  • To evaluate the utility of single-cell RNA sequencing (scRNAseq) in HNSCC research.
  • To explore how scRNAseq can characterize the TME at a cellular level.
  • To address challenges in HNSCC management through advanced cellular analysis.

Main Methods:

  • This review analyzes current strategies employing scRNAseq and other single-cell technologies in HNSCC research.
  • Compilation and critical assessment of existing studies utilizing single-cell approaches.
  • Focus on applications in understanding HNSCC etiology, diagnosis, prognosis, and treatment.

Main Results:

  • scRNAseq facilitates the creation of cellular atlases and identification of cell types in HNSCC.
  • It aids in investigating genes and processes driving HNSCC initiation, development, and progression within the TME.
  • scRNAseq enhances prognostic models by identifying cell type-specific signatures for improved patient outcome assessment.
  • Insights into cellular responses to radiotherapy, chemotherapy, and immunotherapy are provided, improving understanding of treatment efficacy.

Conclusions:

  • scRNAseq significantly contributes to understanding the cellular and biological complexity of HNSCC.
  • This technology holds substantial potential for advancing HNSCC research and clinical practice.
  • The utility of scRNAseq extends to improving research and clinical applications in other cancer types.